Logan Capital Management’s Colgate-Palmolive CL Stock Holding History

Logan Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.38M	Buy	+51,351	New	+$4.58M	0.19%	126

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Logan Capital Management's CL Position: Q1 2026 in Review

Logan Capital Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 36,069 shares — an estimated $3.21M sold.

Logan Capital Management first reported a position in CL in Q1 2021 and held it in 20 quarters. The position peaked at $4.49M in Q4 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Logan Capital Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 36,069 Colgate-Palmolive shares in Q1 2026, an estimated $3.21M.
Logan Capital Management first reported a position in Colgate-Palmolive in Q1 2021 and held it in 20 quarters.
Logan Capital Management's Colgate-Palmolive position peaked at $4.49M in Q4 2024.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.